Genzyme Molecular Oncology receives patent for melanoma immunogens.
D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000628:therapy*; D010330:Patents as Topic
D019496:Cancer Vaccines